Adcentrx Therapeutics Appoints Meng Jiang as Chief Financial Officer
SAN DIEGO and SHANGHAI, April 8, 2024 /PRNewswire/ -- Adcentrx Therapeutics ("Adcentrx"), a biotechnology company revolutionizing Antibody-Drug Conjugate (ADC) therapeutics for cancer and other life-threatening diseases, announced today the appointment of Meng Jiang as Chief Financial Officer (CFO).
- SAN DIEGO and SHANGHAI, April 8, 2024 /PRNewswire/ -- Adcentrx Therapeutics ("Adcentrx"), a biotechnology company revolutionizing Antibody-Drug Conjugate (ADC) therapeutics for cancer and other life-threatening diseases, announced today the appointment of Meng Jiang as Chief Financial Officer (CFO).
- Ms. Jiang joins Adcentrx from CBC Group where she was Senior Managing Director and Management Committee Member.
- "We are delighted to welcome Meng to Adcentrx's executive leadership team," said Hui Li, Ph.D., Founder and CEO of Adcentrx.
- "We are glad to see Meng's continued contributions to Adcentrx as Chief Financial Officer," said Fu Wei, Chief Executive Officer at CBC Group.